Correlation Between Citigroup and BioNTech
Can any of the company-specific risk be diversified away by investing in both Citigroup and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Citigroup and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Citigroup and BioNTech SE, you can compare the effects of market volatilities on Citigroup and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Citigroup with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Citigroup and BioNTech.
Diversification Opportunities for Citigroup and BioNTech
Significant diversification
The 3 months correlation between Citigroup and BioNTech is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Citigroup and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Citigroup is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Citigroup are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Citigroup i.e., Citigroup and BioNTech go up and down completely randomly.
Pair Corralation between Citigroup and BioNTech
Taking into account the 90-day investment horizon Citigroup is expected to generate 2.7 times less return on investment than BioNTech. But when comparing it to its historical volatility, Citigroup is 1.8 times less risky than BioNTech. It trades about 0.06 of its potential returns per unit of risk. BioNTech SE is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 8,572 in BioNTech SE on September 21, 2024 and sell it today you would earn a total of 2,453 from holding BioNTech SE or generate 28.62% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 99.07% |
Values | Daily Returns |
Citigroup vs. BioNTech SE
Performance |
Timeline |
Citigroup |
BioNTech SE |
Citigroup and BioNTech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Citigroup and BioNTech
The main advantage of trading using opposite Citigroup and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Citigroup position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.Citigroup vs. JPMorgan Chase Co | Citigroup vs. Wells Fargo | Citigroup vs. Toronto Dominion Bank | Citigroup vs. Nu Holdings |
BioNTech vs. Samsung Electronics Co | BioNTech vs. Samsung Electronics Co | BioNTech vs. Hyundai Motor | BioNTech vs. Toyota Motor Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Complementary Tools
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |